The cytogenetic and molecular landscape of mycosis fungoides and Sézary syndrome

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

High resolution karyotyping and massive parallel genomic sequencing in mycosis fungoides (MF) and sézary syndrome (SS) have revealed a complex and heterogeneous genomic landscape. Multiple copy number alterations and several DNA sequence mutations are believed to disrupt key intracellular pathways relevant to T-cell and tumor biology, such as T-cell receptor signaling, IL-2/JAK/STAT, NF-κB, MAPK, PI3K/AKT, MYC, TP53, cell cycle checkpoints and epigenetic regulation. Knowledge of the genetic background of cutaneous T-cell lymphoma (CTCL) might contribute to the development of novel targeted therapeutic strategies.

Original languageEnglish (US)
Title of host publicationCutaneous T-Cell Lymphoma (CTCL)
Subtitle of host publicationClinical Features, Diagnosis and Treatment Options
PublisherNova Science Publishers, Inc.
Pages49-56
Number of pages8
ISBN (Electronic)9781536119190
ISBN (Print)9781536118995
StatePublished - Jan 1 2017

Fingerprint

Cutaneous T-Cell Lymphoma
Karyotyping
Mycosis Fungoides
T-Cell Antigen Receptor
Cell Cycle Checkpoints
Phosphatidylinositol 3-Kinases
Epigenomics
Cytogenetics
Interleukin-2
Cell Biology
T-Lymphocytes
Mutation
Neoplasms
Therapeutics
Genetic Background

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Horna, P. (2017). The cytogenetic and molecular landscape of mycosis fungoides and Sézary syndrome. In Cutaneous T-Cell Lymphoma (CTCL): Clinical Features, Diagnosis and Treatment Options (pp. 49-56). Nova Science Publishers, Inc..

The cytogenetic and molecular landscape of mycosis fungoides and Sézary syndrome. / Horna, Pedro.

Cutaneous T-Cell Lymphoma (CTCL): Clinical Features, Diagnosis and Treatment Options. Nova Science Publishers, Inc., 2017. p. 49-56.

Research output: Chapter in Book/Report/Conference proceedingChapter

Horna, P 2017, The cytogenetic and molecular landscape of mycosis fungoides and Sézary syndrome. in Cutaneous T-Cell Lymphoma (CTCL): Clinical Features, Diagnosis and Treatment Options. Nova Science Publishers, Inc., pp. 49-56.
Horna P. The cytogenetic and molecular landscape of mycosis fungoides and Sézary syndrome. In Cutaneous T-Cell Lymphoma (CTCL): Clinical Features, Diagnosis and Treatment Options. Nova Science Publishers, Inc. 2017. p. 49-56
Horna, Pedro. / The cytogenetic and molecular landscape of mycosis fungoides and Sézary syndrome. Cutaneous T-Cell Lymphoma (CTCL): Clinical Features, Diagnosis and Treatment Options. Nova Science Publishers, Inc., 2017. pp. 49-56
@inbook{a9513ac70ae148a38d5fc4d42fc59056,
title = "The cytogenetic and molecular landscape of mycosis fungoides and S{\'e}zary syndrome",
abstract = "High resolution karyotyping and massive parallel genomic sequencing in mycosis fungoides (MF) and s{\'e}zary syndrome (SS) have revealed a complex and heterogeneous genomic landscape. Multiple copy number alterations and several DNA sequence mutations are believed to disrupt key intracellular pathways relevant to T-cell and tumor biology, such as T-cell receptor signaling, IL-2/JAK/STAT, NF-κB, MAPK, PI3K/AKT, MYC, TP53, cell cycle checkpoints and epigenetic regulation. Knowledge of the genetic background of cutaneous T-cell lymphoma (CTCL) might contribute to the development of novel targeted therapeutic strategies.",
author = "Pedro Horna",
year = "2017",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781536118995",
pages = "49--56",
booktitle = "Cutaneous T-Cell Lymphoma (CTCL)",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - The cytogenetic and molecular landscape of mycosis fungoides and Sézary syndrome

AU - Horna, Pedro

PY - 2017/1/1

Y1 - 2017/1/1

N2 - High resolution karyotyping and massive parallel genomic sequencing in mycosis fungoides (MF) and sézary syndrome (SS) have revealed a complex and heterogeneous genomic landscape. Multiple copy number alterations and several DNA sequence mutations are believed to disrupt key intracellular pathways relevant to T-cell and tumor biology, such as T-cell receptor signaling, IL-2/JAK/STAT, NF-κB, MAPK, PI3K/AKT, MYC, TP53, cell cycle checkpoints and epigenetic regulation. Knowledge of the genetic background of cutaneous T-cell lymphoma (CTCL) might contribute to the development of novel targeted therapeutic strategies.

AB - High resolution karyotyping and massive parallel genomic sequencing in mycosis fungoides (MF) and sézary syndrome (SS) have revealed a complex and heterogeneous genomic landscape. Multiple copy number alterations and several DNA sequence mutations are believed to disrupt key intracellular pathways relevant to T-cell and tumor biology, such as T-cell receptor signaling, IL-2/JAK/STAT, NF-κB, MAPK, PI3K/AKT, MYC, TP53, cell cycle checkpoints and epigenetic regulation. Knowledge of the genetic background of cutaneous T-cell lymphoma (CTCL) might contribute to the development of novel targeted therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=85033676737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033676737&partnerID=8YFLogxK

M3 - Chapter

SN - 9781536118995

SP - 49

EP - 56

BT - Cutaneous T-Cell Lymphoma (CTCL)

PB - Nova Science Publishers, Inc.

ER -